Price $5.93 |
Market Cap
102.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.59
|
P/S
2.48
|
Dividend %
-
|
|
P/CF
9.4
|
P/FCF
-
|
Op. Cash Flow
-600
|
FCF
0.0
|
|
Op. Margin
-10.00%
|
Net Margin
-19.40%
|
ROE
-11.90%
|
ROI
-11.30%
|
|
ROA
-8.80%
|
EPS Growth
-756.00%
|
Current Ratio
3.9
|
Debt/Equity
15.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Endo International PLC (ENDP) | $5.97 | - | - | 1.27B | Strong Buy |
| Chembio Diagnostics Inc (CEMI) | $8.85 | - | - | 111.9M | Strong Buy |
| Kalvista Pharmaceuticals Inc (KALV) | $8.62 | - | - | 95.7M | Strong Buy |
| MacroGenics Inc (MGNX) | $21.75 | - | - | 952.9M | Strong Buy |
| Mannatech, Inc. (MTEX) | $20.35 | - | 2.50% | 54.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
